Combined Treatment with Micro-Focused Ultrasound with Visualization and Intradermal Incobotulinumtoxin-A for Enlarged Facial Pores: A Retrospective Study in Asians

References

• Lee SJ, Seok J, Jeong SY, Park KY, Li K, Seo SJ. Facial pores: definition, causes, and treatment options. Dermatologic Surgery. 2016;42:277–285.
   PubMed Web of Science ®Google Scholar
• Park JY, Chen JF, Choi H, et al. Insights on skin quality and clinical practice trends in Asia pacific and a practical guide to good skin quality from the inside out. J Clin Aesthet Dermatol. 2022;15:10–21.
   PubMedGoogle Scholar
• Roh M, Han M, Kim D, Chung K. Sebum output as a factor contributing to the size of facial pores. Br J Dermatol. 2006;155:890–894.
   PubMed Web of Science ®Google Scholar
• Sugiyama-Nakagiri Y, Sugata K, Iwamura M, Ohuchi A, Kitahara T. Age-related changes in the epidermal architecture around facial pores. J Dermatol Sci. 2008;50:151–154.
   PubMed Web of Science ®Google Scholar
• Mizukoshi K, Takahashi K. Analysis of the skin surface and inner structure around pores on the face. Skin Res Technol. 2014;20:23–29.
   PubMed Web of Science ®Google Scholar
• Sugata K, Nishijima T, Kitahara T, Takema Y. Confocal laser microscopic imaging of conspicuous facial pores in vivo: relation between the appearance and the internal structure of skin. Skin Res Technol. 2008;14:208–212.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Shin MK, Back JH, Koh JS. Pore volume is most highly correlated with the visual assessment of skin pores. Skin Res Technol. 2014;20:429–434.
   PubMed Web of Science ®Google Scholar
• Uhoda E, Piérard-Franchimont C, Petit L, Piérard GE. The conundrum of skin pores in dermocosmetology. Dermatology. 2005;210:3–7.
   PubMed Web of Science ®Google Scholar
• Dong J, Lanoue J, Goldenberg G. Enlarged facial pores: an update on treatments. Cutis. 2016;98:33–36.
   PubMed Web of Science ®Google Scholar
• Park JY, Cho SI, Hur K, Lee DH. Intradermal microdroplet injection of diluted incobotulinumtoxin-a for sebum control, face lifting, and pore size improvement. J Drugs Dermatol. 2021;20:49–54.
   PubMed Web of Science ®Google Scholar
• Vachiramon V, Namasondhi A, Anuntrangsee T, Kositkuljorn C, Jurairattanaporn N. A study of combined microfocused ultrasound and hyaluronic acid dermal filler in the treatment of enlarged facial pores in Asians. J Cosmet Dermatol. 2021;20:3467–3474.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Lee KR, Park JY, Yoon MS, Lee SE. The efficacy and safety of intense focused ultrasound in the treatment of enlarged facial pores in Asian skin. J Dermatolog Treat. 2015;26:73–77.
   PubMed Web of Science ®Google Scholar
• Lu PH, Yang CH, Chang YC. Quantitative Analysis of Face and Neck Skin Tightening by Microfocused Ultrasound With Visualization in Asians. Dermatologic Surgery. 2017;43:1332–1338.
   PubMed Web of Science ®Google Scholar
• Sayed KS, Hegazy R, Gawdat HI, et al. The efficacy of intradermal injections of botulinum toxin in the management of enlarged facial pores and seborrhea: a split face-controlled study. J Dermatolog Treat. 2021;32:771–777.
   PubMed Web of Science ®Google Scholar
• Shuo L, Ting Y, KeLun W, Rui Z, Rui Z, Hang W. Efficacy and possible mechanisms of botulinum toxin treatment of oily skin. J Cosmet Dermatol. 2019;18:451–457.
   PubMed Web of Science ®Google Scholar
• Min P, Xi W, Grassetti L, et al. Sebum Production Alteration after Botulinum Toxin Type A Injections for the Treatment of Forehead Rhytides: a Prospective Randomized Double-Blind Dose-Comparative Clinical Investigation. Aesthetic Surgery j. 2015;35:600–610.
   PubMed Web of Science ®Google Scholar
• Rose AE, Goldberg DJ. Safety and efficacy of intradermal injection of botulinum toxin for the treatment of oily skin. Dermatologic Surgery. 2013;39:443–448.
   PubMed Web of Science ®Google Scholar
• Shah AR. Use of intradermal botulinum toxin to reduce sebum production and facial pore size. J Drugs Dermatol. 2008;7:847–850.
   PubMedGoogle Scholar
• Rho NK, Gil YC. Botulinum Neurotoxin Type A in the Treatment of Facial Seborrhea and Acne: evidence and a Proposed Mechanism. Toxins. 2021;13:45.
   PubMed Web of Science ®Google Scholar
• Palawisuth S, Manuskiatti W, Apinuntham C, Wanitphakdeedecha R, Cembrano KAG. Quantitative assessment of the long-term efficacy and safety of a 1064-nm picosecond laser with fractionated microlens array in the treatment of enlarged pores in Asians: a case-control study. Lasers Surg Med. 2022;54:348–354.
   PubMed Web of Science ®Google Scholar
• Park JY, Lin F, Suwanchinda A, et al. Customized Treatment Using Microfocused Ultrasound with Visualization for Optimized Patient Outcomes: a Review of Skin-tightening Energy Technologies and a Pan-Asian Adaptation of the Expert Panel’s Gold Standard Consensus. J Clin Aesthet Dermatol. 2021;14:E70–e9.
   PubMedGoogle Scholar
• Suh DH, Shin MK, Lee SJ, et al. Intense focused ultrasound tightening in Asian skin: clinical and pathologic results. Dermatologic Surgery. 2011;37:1595–1602.
   PubMed Web of Science ®Google Scholar
• White WM, Makin IR, Slayton MH, Barthe PG, Gliklich R. Selective transcutaneous delivery of energy to porcine soft tissues using Intense Ultrasound (IUS). Lasers Surg Med. 2008;40:67–75.
   PubMed Web of Science ®Google Scholar
• Laubach HJ, Makin IR, Barthe PG, Slayton MH, Manstein D. Intense focused ultrasound: evaluation of a new treatment modality for precise microcoagulation within the skin. Dermatologic Surgery. 2008;34:727–734.
   PubMed Web of Science ®Google Scholar
• Shome D, Vadera S, Ram MS, Khare S, Kapoor R. Use of Micro-focused Ultrasound for Skin Tightening of Mid and Lower Face. Plastic Reconstructive Surgery Global Open. 2019;7:e2498.
   PubMedGoogle Scholar
• Fabi SG, Joseph J, Sevi J, Green JB, Peterson JD. Optimizing Patient Outcomes by Customizing Treatment With Microfocused Ultrasound With Visualization: gold Standard Consensus Guidelines from an Expert Panel. J Drugs Dermatol. 2019;18:426–432.
   PubMed Web of Science ®Google Scholar
• Kandhari R, Kaur I, Gupta J, Al-Niaimi F. Microdroplet botulinum toxin: a review. J Cutan Aesthet Surg. 2022;15:101–107.
   PubMedGoogle Scholar
• Park JY, Sunga O, Wanitphakdeedecha R, Frevert J. Neurotoxin impurities: a review of threats to efficacy. Plastic Reconstructive Surgery Global Open. 2020;8:e2627.
   PubMedGoogle Scholar
• Dressler D. Five-year experience with incobotulinumtoxinA (Xeomin(®): the first botulinum toxin drug free of complexing proteins. Eur J Neurol. 2012;19:385–389.
   PubMed Web of Science ®Google Scholar